Logix Biosciences
Team No. 05 Clinical-stage pharmaceutical platform

Coalition

Clinical.
Regulatory.
Pharmacological.

A mission-driven coalition with decades in orthopedic surgery, large-pharma drug development, FDA regulatory strategy, and medical devices.

01

Group 01

Mission Leadership

Gavin Gear

Gavin Gear

Founder & Chief Executive Officer

Nearly two decades isolating and standardizing the biological activity of methylglyoxal. Founder of the Logix dual-asset platform.

Mark Morris

Mark Morris

Co-Founder & Chief Financial Officer

Brett Edmonds

Brett Edmonds

Co-Founder, Board Member

02

Group 02

Clinical & Pharma Operations

Dr. Marc Stevens

Dr. Marc Stevens

Orthopedic Surgeon, Chief Medical Officer

03

Group 03

Regulatory & Data Architecture

RL Johnson

RL Johnson

Head of FDA Regulatory Strategy

Dr. Moj Iram

Dr. Moj Iram

Director of Quality Management Systems

Hanna Miles

Hanna Miles

Manager of QMS & Operations

Khemy Gavrilov

Khemy Gavrilov

Head of Data Management & Analytics

04

Group 04

Specialized Medical & IP

Mike Gentile

Mike Gentile

Head of Medical Device Integration

Stacie Sundquist

Stacie Sundquist

Senior IP Counsel & IP Strategy

Partner

Mayo Clinic

An independent Medical Advisory Board at Mayo Clinic supports the program, applying the reproducibility, quality controls, and peer review of large-pharma drug development.

Mission

Built on a discipline of clinical rigor, the same standards used in large-pharma drug development, applied to a patented class of structurally disruptive antimicrobials.